LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 17.18
(-0.58%)
CNY 17.18
(-0.58%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.35 Billion CNY | 10.82% |
| 2022 | 20.17 Billion CNY | 28.54% |
| 2021 | 15.69 Billion CNY | 12.38% |
| 2020 | 13.96 Billion CNY | 19.75% |
| 2019 | 11.66 Billion CNY | 23.15% |
| 2018 | 9.47 Billion CNY | 26.26% |
| 2017 | 7.5 Billion CNY | 23.09% |
| 2016 | 6.09 Billion CNY | 33.4% |
| 2015 | 4.56 Billion CNY | 15.87% |
| 2014 | 3.94 Billion CNY | 18.72% |
| 2013 | 3.32 Billion CNY | 16.88% |
| 2012 | 2.84 Billion CNY | 15.18% |
| 2011 | 2.46 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.38 Billion CNY | -2.55% |
| 2024 Q1 | 5.52 Billion CNY | -13.27% |
| 2024 Q3 | 5.29 Billion CNY | -1.64% |
| 2023 Q2 | 5.37 Billion CNY | -1.29% |
| 2023 FY | 22.35 Billion CNY | 10.82% |
| 2023 Q4 | 6.36 Billion CNY | 21.72% |
| 2023 Q3 | 5.23 Billion CNY | -2.6% |
| 2023 Q1 | 5.44 Billion CNY | -14.98% |
| 2022 Q1 | 4.14 Billion CNY | -6.22% |
| 2022 FY | 20.17 Billion CNY | 28.54% |
| 2022 Q4 | 6.39 Billion CNY | 33.72% |
| 2022 Q3 | 4.78 Billion CNY | -1.34% |
| 2022 Q2 | 4.85 Billion CNY | 17.14% |
| 2021 Q4 | 4.41 Billion CNY | 15.59% |
| 2021 Q2 | 3.82 Billion CNY | 5.07% |
| 2021 Q1 | 3.63 Billion CNY | -5.43% |
| 2021 Q3 | 3.81 Billion CNY | -0.08% |
| 2021 FY | 15.69 Billion CNY | 12.38% |
| 2020 Q3 | 3.43 Billion CNY | 0.84% |
| 2020 Q1 | 3.28 Billion CNY | -0.34% |
| 2020 Q2 | 3.4 Billion CNY | 3.72% |
| 2020 FY | 13.96 Billion CNY | 19.75% |
| 2020 Q4 | 3.84 Billion CNY | 12.06% |
| 2019 Q3 | 2.83 Billion CNY | 1.07% |
| 2019 Q2 | 2.8 Billion CNY | 2.88% |
| 2019 Q1 | 2.72 Billion CNY | 1.05% |
| 2019 FY | 11.66 Billion CNY | 23.15% |
| 2019 Q4 | 3.29 Billion CNY | 16.12% |
| 2018 Q3 | 2.33 Billion CNY | 4.86% |
| 2018 FY | 9.47 Billion CNY | 26.26% |
| 2018 Q4 | 2.69 Billion CNY | 15.61% |
| 2018 Q1 | 2.21 Billion CNY | -1.42% |
| 2018 Q2 | 2.22 Billion CNY | 0.71% |
| 2017 Q1 | 1.72 Billion CNY | -2.72% |
| 2017 FY | 7.5 Billion CNY | 23.09% |
| 2017 Q4 | 2.24 Billion CNY | 24.29% |
| 2017 Q3 | 1.8 Billion CNY | 4.55% |
| 2017 Q2 | 1.72 Billion CNY | -0.16% |
| 2016 Q2 | 1.44 Billion CNY | 8.39% |
| 2016 Q4 | 1.77 Billion CNY | 14.76% |
| 2016 FY | 6.09 Billion CNY | 33.4% |
| 2016 Q1 | 1.32 Billion CNY | -1.98% |
| 2016 Q3 | 1.54 Billion CNY | 7.5% |
| 2015 Q4 | 1.35 Billion CNY | 20.52% |
| 2015 Q2 | 1.04 Billion CNY | -0.69% |
| 2015 Q1 | 1.04 Billion CNY | -6.33% |
| 2015 Q3 | 1.12 Billion CNY | 8.13% |
| 2015 FY | 4.56 Billion CNY | 15.87% |
| 2014 Q2 | 925.35 Million CNY | -0.2% |
| 2014 Q4 | 1.11 Billion CNY | 15.05% |
| 2014 Q3 | 972.03 Million CNY | 5.05% |
| 2014 FY | 3.94 Billion CNY | 18.72% |
| 2014 Q1 | 927.18 Million CNY | 0.0% |
| 2013 FY | 3.32 Billion CNY | 16.88% |
| 2012 FY | 2.84 Billion CNY | 15.18% |
| 2011 FY | 2.46 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 1.81 Billion CNY | -1128.814% |
| Jointown Pharmaceutical Group Co., Ltd | 149.7 Billion CNY | 85.065% |
| Yifeng Pharmacy Chain Co., Ltd. | 22.58 Billion CNY | 1.017% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 9.08 Billion CNY | -146.22% |